INS and diabetes mellitus: Our results were consistent with these 2 studies that early initiation of insulin after metformin failure, as compared with glimepiride, had high risk of all-cause mortality, CV and noncardiovascular death, after adjusting for all comorbidities and diabetes severity in a Chinese population.